| 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data‐driven methodology … CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ... Arthritis & rheumatology 69 (1), 35-45, 2017 | 2322 | 2017 |
| 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology … MX Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM ... Arthritis Rheumatol 69 (1), 35-45, 2017 | 2321 | 2017 |
| 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology … MX Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM ... Ann Rheum Dis 76 (1), 9-16, 2017 | 2321* | 2017 |
| EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander, ... Annals of the rheumatic diseases 69 (6), 1103-1109, 2010 | 975 | 2010 |
| The cell biology of bone metabolism HK Datta, WF Ng, JA Walker, SP Tuck, SS Varanasi Journal of clinical pathology 61 (5), 577-587, 2008 | 827 | 2008 |
| Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells WF Ng, PJ Duggan, F Ponchel, G Matarese, G Lombardi, AD Edwards, ... Blood, The Journal of the American Society of Hematology 98 (9), 2736-2744, 2001 | 800 | 2001 |
| Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. CCA Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL ... New England Journal of Medicine 386 (4), 316-326, 2022 | 797 | 2022 |
| High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. S Eyre, J Bowes, D Diogo, A Lee, A Barton, P Martin, A Zhernakova, ... Nature Genetics 44 (12), 1336-40, 2012 | 747 | 2012 |
| Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome CJ Lessard, H Li, I Adrianto, JA Ice, A Rasmussen, KM Grundahl, JA Kelly, ... Nature genetics 45 (11), 1284-1292, 2013 | 554 | 2013 |
| EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome R Seror, P Ravaud, X Mariette, H Bootsma, E Theander, A Hansen, ... Annals of the rheumatic diseases 70 (6), 968-972, 2011 | 504 | 2011 |
| EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies M Ramos-Casals, P Brito-Zerón, S Bombardieri, H Bootsma, S De Vita, ... Annals of the rheumatic diseases 79 (1), 3-18, 2020 | 448 | 2020 |
| Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. AKG Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C ... Nature Genetics 41 (12), 1313-8, 2009 | 395 | 2009 |
| Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk et al Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C Nature Genetics 41 (12), 1313-8, 2009 | 395 | 2009 |
| Dendritic cells in transplantation—friend or foe? R Lechler, WF Ng, RM Steinman Immunity 14 (4), 357-368, 2001 | 389 | 2001 |
| EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide R Seror, SJ Bowman, P Brito-Zeron, E Theander, H Bootsma, A Tzioufas, ... RMD open 1 (1), e000022, 2015 | 324 | 2015 |
| Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient … R Seror, H Bootsma, A Saraux, SJ Bowman, E Theander, JG Brun, ... Annals of the rheumatic diseases 75 (2), 382-389, 2016 | 316 | 2016 |
| Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. M RC, P BZ, R S, H B, S J B, T D, Jacques-Eric G, X M, E T, S B, S V, T M, ... Rheumatology (Oxford) 56 (7), 1245, 2017 | 307* | 2017 |
| Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements M Ramos-Casals, P Brito-Zerón, R Seror, H Bootsma, SJ Bowman, ... Rheumatology 54 (12), 2230-2238, 2015 | 307 | 2015 |
| Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI) R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ... Annals of the rheumatic diseases 74 (5), 859-866, 2015 | 303 | 2015 |
| Randomized controlled trial of rituximab and cost‐effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome SJ Bowman, CC Everett, JL O'Dwyer, P Emery, C Pitzalis, WF Ng, ... Arthritis & Rheumatology 69 (7), 1440-1450, 2017 | 269 | 2017 |
